Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Feb;39(2):986–989. doi: 10.1128/iai.39.2.986-989.1983

Effect of Delayed-Type Hypersensitivity Reaction and Transferred Lymphokine on the Resistance of Mice to Salmonella typhimurium Infection

Yoshimura Fukazawa 1, Keiko Kagaya 1, Yoshio Ishibashi 2,†
PMCID: PMC348046  PMID: 6339397

Abstract

Immune mice which exhibited a delayed-type hypersensitivity reaction to bovine serum albumin after bovine serum albumin immunization and stimulation and normal mice that had been transferred with a lymphokine-rich fraction from the supernatant of concanavalin A-stimulated spleen cell cultures demonstrated resistance to Salmonella infection.

Full text

PDF
986

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson S. E., Bautista S., Remington J. S. Induction of resistance to Toxoplasma gondii in human macrophages by soluble lymphocyte products. J Immunol. 1976 Aug;117(2):381–387. [PubMed] [Google Scholar]
  2. Baldwin R. W., Pimm M. V. BCG in tumor immunotherapy. Adv Cancer Res. 1978;28:91–147. doi: 10.1016/s0065-230x(08)60647-8. [DOI] [PubMed] [Google Scholar]
  3. Collins F. M. Vaccines and cell-mediated immunity. Bacteriol Rev. 1974 Dec;38(4):371–402. doi: 10.1128/br.38.4.371-402.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Diamond R. D., Bennett J. E. Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans. J Infect Dis. 1973 Jun;127(6):694–697. doi: 10.1093/infdis/127.6.694. [DOI] [PubMed] [Google Scholar]
  5. Dodd R. Y. Cellular Immunity to Listeria monocytogenes Induced by Sensitization and Challenge with Bovine Gamma Globulin. Infect Immun. 1970 May;1(5):511–512. doi: 10.1128/iai.1.5.511-512.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fidler I. J. Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines. Science. 1980 Jun 27;208(4451):1469–1471. doi: 10.1126/science.7384789. [DOI] [PubMed] [Google Scholar]
  7. Fowles R. E., Fajardo I. M., Leibowitch J. L., David J. R. The enhancement of macrophage bacteriostasis by products of activated lymphocytes. J Exp Med. 1973 Oct 1;138(4):952–964. doi: 10.1084/jem.138.4.952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fukazawa Y., Kagaya K., Miura H. Biological and biochemical characterization of macrophage activating factor (MAF) in murine lymphocytes: role of mannopyranosyl residue of the MAF molecule in macrophage activation. Microbiol Immunol. 1981;25(11):1163–1172. doi: 10.1111/j.1348-0421.1981.tb00124.x. [DOI] [PubMed] [Google Scholar]
  9. Kagaya K., Fukazawa Y. Murine defense mechanism against Candida albicans infection. II. Opsonization, phagocytosis, and intracellular killing of C. albicans. Microbiol Immunol. 1981;25(8):807–818. doi: 10.1111/j.1348-0421.1981.tb00084.x. [DOI] [PubMed] [Google Scholar]
  10. Kirkpatrick C. H., Rich R. R., Bennett J. E. Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med. 1971 Jun;74(6):955–978. doi: 10.7326/0003-4819-74-6-955. [DOI] [PubMed] [Google Scholar]
  11. MACKANESS G. B. Cellular resistance to infection. J Exp Med. 1962 Sep 1;116:381–406. doi: 10.1084/jem.116.3.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mackaness G. B. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969 May 1;129(5):973–992. doi: 10.1084/jem.129.5.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Moulton R. G., Daniels J. C. Effect of lymphokine-containing sera on adenocarcinoma BW10232 and melanoma B16 in C57BL/6 mice. J Natl Cancer Inst. 1980 Apr;64(4):901–903. [PubMed] [Google Scholar]
  14. Papermaster B. W., Gilliland C. D., McEntire J. E., Smith M. E., Buchok S. J. Lymphokine-mediated immunotherapy studies in mouse tumor systems. Cancer. 1980 Mar 15;45(5 Suppl):1248–1253. doi: 10.1002/1097-0142(19800315)45:5+<1248::aid-cncr2820451335>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  15. Paterson P. Y., Semo R., Blumenschein G., Swelstad J. Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy. Clin Exp Immunol. 1971 Nov;9(5):595–602. [PMC free article] [PubMed] [Google Scholar]
  16. Ruco L. P., Meltzer M. S. Macrophage activation for tumor cytotoxicity: increased lymphokine responsiveness of peritoneal macrophages during acute inflammation. J Immunol. 1978 Mar;120(3):1054–1062. [PubMed] [Google Scholar]
  17. Schimpff S. C., Bennett J. E. Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection. J Allergy Clin Immunol. 1975 Jun;55(6):430–441. doi: 10.1016/0091-6749(75)90082-2. [DOI] [PubMed] [Google Scholar]
  18. Sharma S. D., Piessens W. F. Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. I. Development of a short term in vitro microcytotoxicity assay. Cell Immunol. 1978 Apr;37(1):20–30. doi: 10.1016/0008-8749(78)90170-3. [DOI] [PubMed] [Google Scholar]
  19. Simon H. B., Sheagren J. N. Cellular immunity in vitro. I. Immunologically mediated enhancement of macrophage bactericidal capacity. J Exp Med. 1971 Jun 1;133(6):1377–1389. doi: 10.1084/jem.133.6.1377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Smith R. A., Bigley N. J. Detection of delayed hypersensitivity in mice injected with ribonucleic acid-protein fractions of Salmonella typhimurium. Infect Immun. 1972 Sep;6(3):384–389. doi: 10.1128/iai.6.3.384-389.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stendahl O., Tagesson C., Magnusson K. E., Edebo L. Physiochemical consequences of opsonization of Salmonella typhimurium with hyperimmune IgG and complement. Immunology. 1977 Jan;32(1):11–18. [PMC free article] [PubMed] [Google Scholar]
  22. Ushiba D. Two types of immunity in experimental typhoid; "cellular immunity" and "humoral immunity". Keio J Med. 1965 Jun;14(2):45–61. doi: 10.2302/kjm.14.45. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES